Spyre Therapeutics
SYRE
#2075
Rank
NZ$16.22 B
Marketcap
NZ$170.86
Share price
-4.26%
Change (1 day)
295.47%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2026 (TTM): -NZ$0.57 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.41 Billion a decrease over its 2024 earnings that were of -NZ$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.57 Billion39.92%
2025 -NZ$0.41 Billion5.27%
2024 -NZ$0.39 Billion62.23%
2023 -NZ$0.24 Billion51.64%
2022 -NZ$0.16 Billion29.14%
2021 -NZ$0.13 Billion-19.43%
2020 -NZ$0.15 Billion1.43%
2019 -NZ$0.15 Billion76.7%
2018 -NZ$83.11 Million64.27%
2017 -NZ$50.59 Million26.34%
2016 -NZ$40.05 Million93.6%
2015 -NZ$20.69 Million27.08%
2014 -NZ$16.28 Million